Nov 13 2013
Joachim Kohn, the Board of Governors Professor of Chemistry and Chemical Biology at Rutgers University and a research entrepreneur, will speak at UC Riverside at 4:10 p.m. Nov. 20 in Bourns A125.
His talk is titled “Combinatorial Biomaterials Design as a Driver of Innovation in Regenerative Medicine and Commercialization.” The talk is free and open to the public.
In 1997, Kohn founded the New Jersey Center for Biomaterials, which has grown into a collaborative network spanning 25 institutions and 40 laboratories. As a translational scientist, he has 54 issued patents on novel biomaterials and seven companies have licensed his technologies. He has raised about $100 million in research funding at Rutgers and helped four licensees to raise almost $200 million in private capital.
Kohn’s research interests focus on the development of new biomaterials. He pioneered the use of combinatorial and computational methods for the optimization of biomaterials for specific medical applications. He is mostly known for his seminal work on “pseudo-poly(amino acid)s”- a new class of polymers that combine the non-toxicity of individual amino acids with the strength and process ability of high-quality engineering plastics. Medical devices using these materials have been implanted in more than 40,000 patients.